Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
93 pending office actions • 34 clients • 85 examiners • 50 art units • 0 of 93 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 30 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 30 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (2%) |
| §101 + other | 6 (6%) |
| §103 only | 22 (24%) |
| §102 only | 2 (2%) |
| §112 only | 6 (6%) |
| Double-patenting only | 2 (2%) |
| Double-patenting + other | 14 (15%) |
| Multi-statute (no §101) | 37 (40%) |
| No statute on record | 2 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MORILLO, JANELL COMBS | 3 | 58.0% | +25.8% |
| LUK, VANESSA TIBAY | 2 | 54.4% | +26.3% |
| RAHMANI, NILOOFAR | 2 | 77.5% | -2.9% |
| PRAKASH, SUBBALAKSHMI | 2 | 45.7% | +36.1% |
| ZHENG, LOIS L | 2 | 67.6% | +13.0% |
| MORGAN, BAILEY MICHELLE | 2 | 56.3% | +58.3% |
| HAWKINS, AMANDA SALATA | 2 | 12.0% | +45.2% |
| MORENO, LARK JULIA | 1 | 0.0% | +0.0% |
| BEHA, CAROLINE | 1 | 57.5% | +23.8% |
| COLEMAN, BRENDA LIBBY | 1 | 74.9% | +15.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18178055 | PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS | FONTAINHAS, AURORA M | 153d overdue |
| 17414839 | PHAGE RESISTANT LACTIC ACID BACTERIA | SWIFT, CANDICE LEE | 91d overdue |
| 15734727 | MODIFIED RAPESEED PROTEIN ISOLATE | TRAN, LIEN THUY | 45d overdue |
| 17764104 | IMMUNOGENIC EGFR PEPTIDE COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER | PATTERSON, SARAH COOPER | 43d overdue |
| 17771391 | PROTEIN KINASE INHIBITORS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE DISEASES | MCANANY, JOHN D | 26d overdue |
| 18548983 | FROZEN FOOD PRODUCT, NATURAL STABILIZER, FROZEN FOOD PRODUCTION METHOD AND THE SIEVE SYSTEM | BEKKER, KELLY JO | 9d overdue |
| 18002928 | NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES | HEITMEIER, KENDALL NICOLE | 3d overdue |
| 18551454 | DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1) | COUNTS, GARY W | 5d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18546604 | COATED MEAT OR FISH SUBSTITUTE | PRAKASH, SUBBALAKSHMI | 112d overdue |
| 17415590 | AL-ZN-CU-MG ALLOYS AND THEIR MANUFACTURING PROCESS | MORILLO, JANELL COMBS | 49d overdue |
| 17282326 | PROCESS FOR MANUFACTURING AN ALUMINUM ALLOY PART | LUK, VANESSA TIBAY | 42d overdue |
| 18291819 | PROCESS FOR PRODUCTION OF A FERMENTED MILK PRODUCT USING GLUCOSE-FRUCTOSE OXIDOREDUCTASE | PRAKASH, SUBBALAKSHMI | 12d |
| 17906118 | USE OF PHYTASE TO OBTAIN IMPROVED FOOD | HAWKINS, AMANDA SALATA | 26d |
| 17842842 | PROCESS FOR PRODUCING OLIVE OIL | HAWKINS, AMANDA SALATA | 34d |
| 18861903 | ARTICLE SUITABLE FOR FOOD CONTACT AND METHOD FOR PRODUCING SAME | BEHA, CAROLINE | — |
| 18851859 | SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS | COLEMAN, BRENDA LIBBY | — |
| Art Unit | Apps |
|---|---|
| 1793 | 8 |
| 1733 | 7 |
| 1759 | 3 |
| 1675 | 3 |
| 1645 | 3 |
| 1642 | 3 |
| 1691 | 2 |
| 1651 | 2 |
| 1671 | 2 |
| 1615 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19384727 | WINE DEHAZING METHODS AND COMPOSITIONS | Vinzymes, Inc. | MORENO, LARK JULIA | 1793 | §102§103 | Final Rejection | — | Pending | Nov 10, 2025 |
| 18861903 | ARTICLE SUITABLE FOR FOOD CONTACT AND METHOD FOR PRODUCING SAME | Elkem Silicones France SAS | BEHA, CAROLINE | 1748 | §102§103§112 | Non-Final OA | — | Pending | Oct 31, 2024 |
| 18851859 | SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS | The United States Department of Health and Human Services | COLEMAN, BRENDA LIBBY | 1624 | §102§112 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18891013 | SULFONATED AND PHOSPHORYLATED AROMATIC MOLECULES | Xavier University Of Louisiana | BAUER, BRIANNA LEE | §103§112 | Non-Final OA | — | Pending | Sep 20, 2024 | |
| 18887856 | COMPOSITIONS OF GRAPIPRANT AND METHODS FOR USING THE SAME | Aratana Therapeutics Inc. | MCMILLIAN, KARA RENITA | §103Other | Non-Final OA | — | Pending | Sep 17, 2024 | |
| 18793061 | GLYCATED PROTEIN SENSOR, MEASUREMENT METHOD, PROGRAM, AND SENSOR MANUFACTURE METHOD | Provigate Inc. | KAUR, GURPREET | 1759 | §102§103 | Non-Final OA | — | Pending | Aug 02, 2024 |
| 18730668 | MOLIDUSTAT FORMULATIONS AND METHODS OF USE FOR TREATMENT OF ANEMIA IN CATS | Elanco Animal Health GmbH | KIM, SEONG JONG | §102§103§112 | Non-Final OA | — | Pending | Jul 19, 2024 | |
| 18714745 | 6XXX SERIES ALUMINIUM ALLOY SHEETS OR BLANKS WITH IMPROVED FORMABILITY | Constellium Neuf-Brisach | ALDAZ CERVANTES, MAYELA RENATA | §102§103§112Other | Non-Final OA | — | Pending | May 30, 2024 | |
| 18649164 | ALUMINUM-COPPER-LITHIUM ALLOY PRODUCTS | Constellium Issoire | LUK, VANESSA TIBAY | 1733 | §103§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18647837 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | Immatics Biotechnologies GmbH | OUSPENSKI, ILIA I | §112DP | Non-Final OA | — | Pending | Apr 26, 2024 | |
| 18694487 | STABLE FORMULATIONS OF BUPRENORPHINE | Elanco US Inc. | RAHMANI, NILOOFAR | 1691 | §102 | Final Rejection | — | Pending | Mar 22, 2024 |
| 18691184 | HIGH-MOISTURE TEXTURIZED VEGETABLE PROTEIN | DSM IP ASSETS B.V. | LIU, DEBORAH YANG-HAO | 1791 | §103 | Final Rejection | 8d overdue | Pending | Mar 12, 2024 |
| 18690087 | NEW QUINOLINE DERIVATIVES | Elanco Animal Health GmbH | SHTERENGARTS, SAMANTHA L | 1623 | §102DP | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18594869 | CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC) | DSM IP ASSETS B.V. | REGA, KYLE THOMAS | 1636 | §103 | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18588777 | ENZYME COMPOSITION | DSM IP ASSETS B.V. | MONSHIPOURI, MARYAM | 1651 | §112 | Final Rejection | — | Pending | Feb 27, 2024 |
| 18685689 | NEURAL-NETWORK-BASED CLASSIFIER | Craif Inc. | MESFIN, MATTHEWOS | §102§103 | Non-Final OA | — | Pending | Feb 22, 2024 | |
| 18291819 | PROCESS FOR PRODUCTION OF A FERMENTED MILK PRODUCT USING GLUCOSE-FRUCTOSE OXIDOREDUCTASE | DSM IP ASSETS B.V. | PRAKASH, SUBBALAKSHMI | 1793 | §103 | Final Rejection | 12d | Pending | Jan 24, 2024 |
| 18580849 | PEA AND RAPESEED PROTEIN ISOLATE | DSM IP ASSETS B.V. | MCCLAIN, TYNESHA L. | 1793 | §102§103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18579769 | METHOD OF TREATING DRUG RESISTANT ESKAPEE PATHOGENS USING THERAPEUTIC BACTERIOPHAGES | The United States Government (Department of the Army) | GILL, RACHEL B | 1671 | §102§112 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18576593 | PROCESS FOR MAKING DIARYL ISOXAZOLINE DERIVATIVE | Elanco US Inc. | BARBER, KIMBERLY | 1615 | §112DP | Final Rejection | — | Pending | Jan 04, 2024 |
| 18396656 | AUTOMATIC EXTRACTION DEVICE AND USE METHOD THEREFOR | Nanjing Genscript Biotech Co., Ltd. | WASHINGTON, BRITNEY NICOLE | §103 | Final Rejection | — | Pending | Dec 26, 2023 | |
| 18533733 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS | Immatics Biotechnologies GmbH | SANG, HONG | §102§103§112DP | Non-Final OA | — | Pending | Dec 08, 2023 | |
| 18567588 | ALUMINUM ALLOY PLATE SHEET FOR PARALLELEPIPED BATTERY HOUSING | Constellium Rolled Products Singen GmbH & Co.Kg | ROE, JESSEE RANDALL | 1759 | §102§103§112 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18529656 | AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY NON-HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | Immatics Biotechnologies GmbH | ESSEX, LAURA ANN | 1649 | §112Other | Non-Final OA | — | Pending | Dec 05, 2023 |
| 18565741 | SEMICONDUCTOR SUBSTRATE ASSEMBLY AND MANUFACTURING METHOD THEREFOR | BONDTECH CO., LTD. | RIRIE, EVERETT TRAJAN | 2897 | §103 | Final Rejection | — | Pending | Nov 30, 2023 |
| 18564921 | RECOMBINANT PROTEINACEOUS BINDING MOLECULES | Julius-Maximilians-Universitaet Wuerzburg | NICKOL, GARY B | §101§102§112 | Non-Final OA | — | Pending | Nov 28, 2023 | |
| 18563134 | FED-BATCH FERMENTATION PROCESS | DSM IP ASSETS B.V. | HURST, JONATHAN M | 1799 | §102§103§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18561758 | A 6XXX ALLOY FOR HIGH STRENGTH EXTRUDED PRODUCTS WITH HIGH PROCESSABILITY | CONSTELLIUM EXTRUSIONS LEVICE S.R.O. | MORILLO, JANELL COMBS | 1733 | §102§103 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18560853 | FISH FLAVOUR AND FISH ANALOGUE PRODUCT | DSM IP ASSETS B.V. | LACHICA, ERICSON M | 1792 | §103§112 | Non-Final OA | 34d | Pending | Nov 14, 2023 |
| 18505361 | METHODS OF IDENTIFYING METASTATIC LESIONS IN A PATIENT AND TREATING THEREOF | Immatics Biotechnologies GmbH | REDDIG, PETER J | 1646 | §103DP | Non-Final OA | — | Pending | Nov 09, 2023 |
| 18498631 | ANTI-GUCY2C ANTIBODY AND USES THEREOF | Heidelberg Pharma Research GmbH | DONOGHUE, BRITTNEY ERIN | 1675 | §112DP | Non-Final OA | — | Pending | Oct 31, 2023 |
| 18558222 | STRIP OR SHEET OF ALUMINIUM ALLOY FOR MANUFACTURING BRAZED HEAT EXCHANGERS | Constellium Neuf-Brisach | ZHENG, LOIS L | 1733 | §103Other | Final Rejection | — | Pending | Oct 31, 2023 |
| 18558040 | 5XXX ALUMINIUM SHEETS FOR CAN MAKING | Constellium Rolled Products Singen GmbH & Co. Kg | CHRISTY, KATHERINE A | 1784 | §103 | Final Rejection | 4d overdue | Pending | Oct 30, 2023 |
| 18556008 | 5XXX ALUMINIUM SHEETS WITH HIGH FORMABILTY | Constellium Neuf-Brisach | KESSLER, CHRISTOPHER S | 1759 | §102§103§112 | Non-Final OA | — | Pending | Oct 18, 2023 |
| 18553817 | ENZYME COMPOSITION | DSM IP ASSETS B.V. | FRONDA, CHRISTIAN L | 1652 | DP | Non-Final OA | — | Pending | Oct 03, 2023 |
| 18551454 | DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1) | Celltrend GmbH | COUNTS, GARY W | 1678 | §101 | Final Rejection | 5d | Pending | Sep 20, 2023 |
| 18548983 | FROZEN FOOD PRODUCT, NATURAL STABILIZER, FROZEN FOOD PRODUCTION METHOD AND THE SIEVE SYSTEM | Krzysztof Ciuhak | BEKKER, KELLY JO | 1792 | §102§103§112 | Final Rejection | 9d overdue | Pending | Sep 05, 2023 |
| 18546604 | COATED MEAT OR FISH SUBSTITUTE | DSM IP ASSETS B.V. | PRAKASH, SUBBALAKSHMI | 1793 | §103 | Non-Final OA | 112d overdue | Pending | Aug 16, 2023 |
| 18448998 | THICK PLATES MADE OF AL-CU-LI ALLOY WITH IMPROVED FATIGUE PROPERTIES | Constellium Issoire | WALCK, BRIAN D | 1738 | §103§112 | Non-Final OA | — | Pending | Aug 14, 2023 |
| 18366306 | IMMUNOSTIMULATORY OLIGONUCLEOTIDES | Elanco Animal Health GmbH | RAHMAN, MASUDUR | 1633 | §103§112 | Non-Final OA | 34d | Pending | Aug 07, 2023 |
| 18361018 | METHOD FOR REDUCING SURFACE TENSION OF POLYMER MATERIAL AND METHOD FOR CONTROLLING ORIENTATION OF BLOCK COPOLYMER THIN FILM BY DECOMPRESSION EFFECT | National Tsing Hua University | BHUSHAN, KUMAR R | 1766 | §102 | Non-Final OA | — | Pending | Jul 28, 2023 |
| 18262975 | VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE | BAYER AKTIENGESELLSCHAFT | MORGAN, BAILEY MICHELLE | 1645 | §103§112DP | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18262949 | VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE | Elanco Animal Health GmbH | MORGAN, BAILEY MICHELLE | 1645 | §103§112DP | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18262043 | METHOD AND APPARATUS FOR EVALUATING DEGREE OF GLYCATION OF PROTEIN | Provigate Inc. | HUANG, MICKEY NMN | 1758 | §103 | Final Rejection | 19d overdue | Pending | Jul 19, 2023 |
| 18262125 | MICROPLATE, MEASUREMENT METHOD USING THE SAME, AUTOMATIC MEASUREMENT SYSTEM, AND PROGRAM | Provigate Inc. | HERON, VELVET ELIZABETH | 1798 | §102§103 | Non-Final OA | — | Pending | Jul 19, 2023 |
| 18347724 | PHENYL UNSATURATED KETONES AS HUMAN FACTOR XIIIA INHIBITORS FOR TREATMENT OF THROMBOEMBOLIC DISEASES | Xavier University Of Louisiana | DEKARSKE, MADELINE MCGUIRE | 1622 | §102§103 | Final Rejection | 13d | Pending | Jul 06, 2023 |
| 18345700 | PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS | Immatics Biotechnologies GmbH | CANELLA, KAREN A | §112 | Non-Final OA | — | Pending | Jun 30, 2023 | |
| 18343502 | TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS | Immatics Biotechnologies GmbH | SKELDING, ZACHARY S | 1644 | §112Other | Non-Final OA | — | Pending | Jun 28, 2023 |
| 18258071 | TNF ALPHA AND NGF ANTIBODIES FOR VETERINARY USE | Elanco US, Inc. | STONEBRAKER, ALYSSA RAE | 1642 | §102§103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18255134 | BICYCLIC DERIVATIVES | Elanco Tiergesundheit AG | HERNANDEZ, JACKSON J | 1627 | §103DP | Final Rejection | — | Pending | May 31, 2023 |
| 18324203 | MANUFACTURING PROCESS FOR OBTAINING HIGH STRENGTH EXTRUDED PRODUCTS MADE FROM 6XXX ALUMINIUM ALLOYS | CONSTELLIUM SINGEN GMBH | MORILLO, JANELL COMBS | 1733 | §103§112 | Final Rejection | — | Pending | May 26, 2023 |
| 18323577 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS | Immatics Biotechnologies GmbH | YOUTCHOM PENDIE, EMMANUEL LED | 1647 | Other | Non-Final OA | 34d | Pending | May 25, 2023 |
| 18253061 | N-(2,3-DIHYDRO-1,4-BENZOXAZIN-4-YL)-3-ISOPROPYL-7-(2,3,5-TRIFLUOROPHENYL)BENZO-THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND SIMILAR COMPOUNDS FOR THE TREATMENT OF HEARTWORM INFECTIONS | Elanco Tiergesundheit AG | LEE, CHIHYI NMN | 1628 | §102§103§112DP | Final Rejection | 60d overdue | Pending | May 16, 2023 |
| 18318133 | VETERINARY PHARMACEUTICAL FORMULATIONS | Increvet, Inc. | SASAN, ARADHANA | 1615 | §103Other | Final Rejection | — | Pending | May 16, 2023 |
| 18315183 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | Immatics Biotechnologies GmbH | MOSELEY II, NELSON B | 1642 | Other | Non-Final OA | 27d | Pending | May 10, 2023 |
| 18309062 | DOMINANT NEGATIVE TGFBETA RECEPTOR POLYPEPTIDES, CD8 POLYPEPTIDES, CELLS, COMPOSITIONS, AND METHODS OF USING THEREOF | Immatics US, Inc. | GROOMS, TIFFANY NICOLE | 1637 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 28, 2023 |
| 18303967 | BIODEGRADABLE THERMOPLASTIC MATERIALS | Dizolv, Inc. | DESTEFANO, AUDRA JEAN | 1766 | §103 | Non-Final OA | — | Pending | Apr 20, 2023 |
| 18300750 | SILICONE FOAM WHICH IS AIR FOAMED AND SYNTACTIC AND ARTICLE SUCH AS A SECONDARY BATTERY PACK COMPRISING SAID FOAM | Elkem Silicones Usa Corp. | KRYLOVA, IRINA | 1764 | §103§112 | Non-Final OA | — | Pending | Apr 14, 2023 |
| 18248781 | METHOD FOR EVALUATING LIKELIHOOD OF OBSERVATION VALUE AND PROGRAM | Craif Inc. | SABOUR, GHAZAL | §101§103§112 | Non-Final OA | — | Pending | Apr 12, 2023 | |
| 18028390 | HEAT SHRINKABLE FILMS, AND METHOD OF MANUFACTURING THE SAME | Klöckner Pentaplast Of America, Inc. | CHEN, VIVIAN | 1787 | §103§112 | Non-Final OA | — | Pending | Mar 24, 2023 |
| 18025118 | FLUID RETAINING SUBSTRATE | Linpac Packaging Limited | COLLINS, RAVEN | 3735 | §102§103 | Non-Final OA | — | Pending | Mar 07, 2023 |
| 18178055 | PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS | Immatics Biotechnologies GmbH | FONTAINHAS, AURORA M | 1675 | §101Other | Non-Final OA | 153d overdue | Pending | Mar 03, 2023 |
| 18043868 | CHEWABLE FORMULATIONS | Elanco Tiergesundheit AG | SONG, JIANFENG | 1613 | §103§112 | Final Rejection | 14d | Pending | Mar 02, 2023 |
| 18043663 | PLUNGER AND FINGER GRIP FOR A SYRINGE ASSEMBLY, METHOD FOR MAKING THEM, SYRINGE ASSEMBLY, KIT AND USE OF THE SAME | Merz Pharma GmbH & Co. Kgaa | PRICE, NATHAN R | 3783 | §102§103§112 | Final Rejection | — | Pending | Mar 01, 2023 |
| 18006361 | SYSTEM AND METHODS FOR DETECTION OF PATHOGENIC VIRUSES | Viroforge Technologies, LLC | ALLEN, MICHAEL D | 1671 | §103§112DP | Non-Final OA | — | Pending | Jan 20, 2023 |
| 18002928 | NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES | Elanco Animal Health GmbH | HEITMEIER, KENDALL NICOLE | 1621 | §102§103§112Other | Final Rejection | 3d overdue | Pending | Dec 22, 2022 |
| 18000307 | LIQUID COLLECTOR AND METHOD FOR COLLECTING LIQUID | Provigate Inc. | KASS, BENJAMIN JOSEPH | 1797 | §102§103§112 | Non-Final OA | — | Pending | Nov 30, 2022 |
| 18053705 | ADOPTIVE CELL THERAPY COMBINATION TREATMENT AND COMPOSITIONS THEREOF | Immatics US, Inc. | LU, CHENG | 1642 | §103DP | Final Rejection | 6d | Pending | Nov 08, 2022 |
| 18052009 | RECRUITING AGENT FURTHER BINDING AN MHC MOLECULE | Immatics Biotechnologies GmbH | DUFFY, BRADLEY | 1643 | DP | Final Rejection | — | Pending | Nov 02, 2022 |
| 17906826 | THE COMBINED USE OF PHYTASE AND PAD TO OBTAIN AN IMPROVED PLANT-BASED DRINK | DSM IP ASSETS B.V. | TURNER, FELICIA C | 1793 | §103 | Final Rejection | — | Pending | Sep 20, 2022 |
| 17906118 | USE OF PHYTASE TO OBTAIN IMPROVED FOOD | DSM IP ASSETS B.V. | HAWKINS, AMANDA SALATA | 1793 | §103 | Final Rejection | 26d | Pending | Sep 12, 2022 |
| 17842842 | PROCESS FOR PRODUCING OLIVE OIL | DSM IP ASSETS B.V. | HAWKINS, AMANDA SALATA | 1793 | §103 | Final Rejection | 34d | Pending | Jun 17, 2022 |
| 17828744 | THERMOFORMABLE FILM FOR BARRIER PACKAGING AND METHODS OF FORMING THE SAME | Klöckner Pentaplast Of America, Inc. | SHUKLA, KRUPA | 1787 | §103 | Non-Final OA | — | Pending | May 31, 2022 |
| 17771732 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Elanco Animal Health GmbH | RODRIGUEZ-GARCIA, VALERIE | 1621 | §112 | Non-Final OA | — | Pending | Apr 25, 2022 |
| 17771391 | PROTEIN KINASE INHIBITORS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE DISEASES | Xavier University Of Louisiana | MCANANY, JOHN D | 1625 | §102§103 | Final Rejection | 26d overdue | Pending | Apr 22, 2022 |
| 17767018 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Elanco Animal Health GmbH | NESTOR, DONNA MICHELLE | 1627 | §103§112DP | Final Rejection | — | Pending | Apr 06, 2022 |
| 17764710 | APPARATUS AND METHOD FOR SLEEP-DISORDERED BREATHING ESTIMATION BASED ON SOUND ANALYSIS | Mari Co., Ltd. | CATINA, MICHAEL ANTHONY | 3791 | §101§103 | Non-Final OA | — | Pending | Mar 29, 2022 |
| 17764104 | IMMUNOGENIC EGFR PEPTIDE COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | PATTERSON, SARAH COOPER | 1675 | §103§112 | Final Rejection | 43d overdue | Pending | Mar 25, 2022 |
| 17762325 | TREATMENT AND PREVENTION OF AGING RELATED-DISEASE AND/OR AGING BY THE INHIBITION OF SPHINGOLIPIDS | ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE | RAHMANI, NILOOFAR | 1691 | §112 | Non-Final OA | 7d | Pending | Mar 21, 2022 |
| 17608429 | MULTIPARTITE CRISPR DONOR | DSM IP ASSETS B.V. | LEITH, NANCY J | 1600 | §102§112Other | Non-Final OA | — | Pending | Nov 02, 2021 |
| 17434262 | MACROCYCLIC LACTONE ANTHELMINTICS AGAINST NEMATODES | BAYER AKTIENGESELLSCHAFT | BAEK, BONG-SOOK | 1611 | §103 | Final Rejection | — | Pending | Aug 26, 2021 |
| 17432391 | DRUG DELIVERY SILICONE COMPOSITION TO IMPROVE ACTIVE INGREDIENT ELUTION | Elkem Silicones Germany GmbH | BOATENG, AFUA BAMFOAA | 1617 | §103 | Final Rejection | 29d | Pending | Aug 19, 2021 |
| 17431997 | NOVEL USES OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF TREMOR | Merz Pharma GmbH & Co. Kgaa | GOUGH, TIFFANY MAUREEN | 1651 | §103DP | Final Rejection | 44d overdue | Pending | Aug 18, 2021 |
| 17424671 | METHOD FOR MANUFACTURING A PART FROM ALUMINIUM ALLOY, THE ALLOY COMPRISING AT LEAST ZIRCONIUM AND MAGNESIUM | C-Tec Constellium Technology Center | SMITH, CATHERINE P | 1735 | §103 | Non-Final OA | — | Pending | Jul 21, 2021 |
| 17423394 | CONTINUOUS SURFACE TREATMENT FOR COILS MADE OF ALUMINUM ALLOYS SHEETS | Constellium Bowling Green LLC | ZHENG, LOIS L | 1733 | §103§112 | Final Rejection | — | Pending | Jul 15, 2021 |
| 17415590 | AL-ZN-CU-MG ALLOYS AND THEIR MANUFACTURING PROCESS | Constellium Issoire | MORILLO, JANELL COMBS | 1733 | §103 | Final Rejection | 49d overdue | Pending | Jun 17, 2021 |
| 17258670 | HEALTHCARE MANAGEMENT METHOD | Provigate Inc. | HRANEK, KAREN AMANDA | 3684 | §101§112 | Non-Final OA | 9d | Pending | Jun 16, 2021 |
| 17414839 | PHAGE RESISTANT LACTIC ACID BACTERIA | DSM IP ASSETS B.V. | SWIFT, CANDICE LEE | 1657 | §102§103§112Other | Final Rejection | 91d overdue | Pending | Jun 16, 2021 |
| 17327271 | METHODS FOR DETECTING proADM IN A CRITICALLY ILL SUBJECT WHO HAS BEEN ADMITTED TO AN INTENSIVE CARE UNIT | B.R.A.H.M.S GmbH | SAOUD, CHRISTINE J | 1645 | §101§112DP | Non-Final OA | — | Pending | May 21, 2021 |
| 17284875 | Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use | Elanco US Inc. | NGUYEN, NAM P | 1678 | §103§112 | Final Rejection | — | Pending | Apr 13, 2021 |
| 17282326 | PROCESS FOR MANUFACTURING AN ALUMINUM ALLOY PART | C-Tec Constellium Technology Center | LUK, VANESSA TIBAY | 1733 | §103 | Final Rejection | 42d overdue | Pending | Apr 01, 2021 |
| 15734727 | MODIFIED RAPESEED PROTEIN ISOLATE | DSM IP ASSETS B.V. | TRAN, LIEN THUY | 1793 | §103§112 | Non-Final OA | 45d overdue | Pending | Dec 03, 2020 |
| 17051672 | METHOD FOR MANUFACTURING AN ALUMINUM-COPPER-LITHIUM ALLOY HAVING IMPROVED COMPRESSIVE STRENGTH AND IMPROVED TOUGHNESS | Constellium Issoire | OMORI, MARY I | 1784 | §103Other | Non-Final OA | 43d overdue | Pending | Oct 29, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial